Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion

Yuhang Liu1, Kyle P Heim2, Ye Che3

  • 1Discovery Sciences, Pfizer Inc., Groton, CT 06340, USA. yuhang.liu@pfizer.com philip.dormitzer@pfizer.com.

Science Advances
|March 6, 2021
PubMed

Insights

Researchers determined the structure of human cytomegalovirus glycoprotein B (gB) in its prefusion state. This structure provides a foundation for developing new HCMV vaccines targeting prefusion gB.

Area of Science:

  • Virology
  • Structural Biology
  • Immunology

Background:

  • Human cytomegalovirus (HCMV) is a significant cause of congenital disease and long-term infant morbidity.
  • HCMV glycoprotein B (gB) is essential for viral entry, mediating fusion between the viral envelope and host cell membrane via a conformational transition from prefusion to postfusion states.

Purpose of the Study:

  • To determine the high-resolution structure of HCMV glycoprotein B (gB) in its metastable prefusion conformation.
  • To elucidate the structural mechanisms underlying membrane fusion mediated by gB.
  • To provide a structural basis for the rational design of HCMV vaccine antigens.

Main Methods:

  • Stabilization of prefusion gB on the virion using a fusion inhibitor and chemical cross-linking.
  • Extraction and purification of stabilized prefusion gB.
  • Determination of the gB structure using electron cryomicroscopy (cryo-EM) at 3.6-Å resolution.

Main Results:

  • The cryo-EM structure revealed detailed interactions stabilizing prefusion gB, including those involving fusion loops, the membrane-proximal region, and the transmembrane domain.
  • The structure elucidated the molecular rearrangements critical for mediating membrane fusion.
  • The determined structure rationalizes known antigenic sites on gB.

Conclusions:

  • The high-resolution structure of prefusion HCMV gB offers a blueprint for engineering stabilized prefusion antigens.
  • This structural information can guide the development of novel HCMV vaccines aimed at eliciting protective immunity.
  • The findings contribute to understanding viral entry mechanisms and developing strategies against HCMV congenital infections.

Related Concept Videos

Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
70.2K
SNAREs and Membrane Fusion01:43

SNAREs and Membrane Fusion

Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
11.8K
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.1K
Coat Assembly and GTPases01:33

Coat Assembly and GTPases

Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
4.0K
Mechanisms of Membrane Domain Formation00:59

Mechanisms of Membrane Domain Formation

Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with...
3.5K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.3K